completely new strength [Regulatives / Guidelines]

posted by Clarc Homepage – Romania, 2013-10-24 15:06 (4630 d 15:48 ago) – Posting: # 11747
Views: 4,161

Thanks John for all the advices

❝ That's a bit monumental for developing a "middle" strength(s) generic of a product, don't you think? This might be out of line but what is the benefit of 35 and 70 mg strengths of your client's product?


Yes it can be monumental, however if the sponsor can afford it, I'm not questioning his will. :-D
Now seriously: the sponsor performed some clinical trials (not in EU) and they concluded that the 35 mg test has the same clinical efficiency as the 50 mg reference. The same applies to the 70 mg vs. the 100 mg reference. If this is true, than this middle strength generic will be better tolerated by the patient (think on AE's, and of course on the price too), and the better (anticipated) compliance will make it much more cost-effective versus the concurrent generics. (....my guess)

I'm always tryin' to do something new, tryin' to look like a beginner.
Meshell Ndegeocello

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
223 visitors (0 registered, 223 guests [including 12 identified bots]).
Forum time: 06:54 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5